Bringing Together Leaders In Healthcare To Discuss The Industry's Most Pressing Topics

Leading the Conversation 2019, powered by Navigant Consulting in partnership with Medical Alley Association, will call into question the fundamental supposition of value-based healthcare: that value is defined as outcomes divided by cost. Even with that framework, value is still difficult to articulate, much less implement, making the equation something less than formulaic.

Outcomes seem like they should be easy to understand: Given the situation, did the patient get a favorable result? Yet we all know it is not that simple. Is a good outcome for a patient the same as good outcome for other stakeholders: providers, payors, technology companies, the government, etc. Price should be even clearer: How much was charged? Yet anyone who has had an encounter with the healthcare system knows finding the price is difficult and the answer changes based on any one of innumerable factors.

In this two-part series, we will explore this equation and its component parts with a focus on real world examples of organizations solving for the value equation.

Our first event, “Where are the ‘New and Improved’ Outcomes in Health? Outcomes, Value-Based Care, and the Evolving Health Business Model” explored how the business of healthcare is transforming. The event brought payors, providers, and technology leaders together to highlight successful partnerships, challenges to expanding the model, and delving into the work yet to be done to outline how the Medical Alley community can help proven models reach more people.

The second event, “Does Price Transparency Matter?” will challenge one of the biggest assumptions in improving healthcare: price transparency will lead to better costs, quality, and outcomes. This second Conversation will be a spirited discussion focused on the meaning of cost, how it correlates to outcomes, and how today’s healthcare leaders are addressing the issue.

Attendees will gain insights on healthcare’s future from the people at the forefront of implementing value-based care, improving outcomes in health, and preparing for the change’s attendant challenges.



Leading The Conversation: Does Price Transparency Matter?

Healthcare is routinely criticized for a lack of price transparency. This criticism seems to imply that price transparency would make healthcare better: better outcomes, lower prices, and overall better value. Is that true?

In the second of a two-part series, “Leading the Conversation: Does Price Transparency Matter?” will challenge this criticism and engage health leaders in uncovering the challenges to improving outcomes, lowering costs, and delivering value in a price-conscience world.

Wednesday, November 6

12:30 - 5:30 PM

$99 Members

$299 Non-Members

The Depot

Minneapolis, MN

Thursday, Nov 29

7:30 AM - 2:30 PM

$129 Members

$299 Non-Members

Location TBD

Thank You To Our Sponsors

q&a with healthcare leaders

For The Record with TABATHA ERCK


Tabatha is responsible for leading the Amplifon Hearing Health Care team. Previously, Tabatha served as Chief Executive Officer for Fulcrum Health, Inc. and was most recently Vice President, Shared Services Operations, for Superior HealthPlan, a managed health-care company. Her career has also included leadership roles at HealthPartners, Vivius, Medica, and LifeScan. Tabatha has led organizational transformations in her past organizations and has an impressive track record of growing businesses, people, and team spirit. 

For The Record with JEFFERY LEIBACH


Jeff Leibach is Director with Navigant's Healthcare Strategic Solutions team, supporting clients as they manage the financial and strategic challenges in today's rapidly changing healthcare landscape. Jeff's areas of expertise include managed care negotiations, pricing and reimbursement analytics, and aligning clinical and financial leadership as providers and payers weigh the transition from fee-for-service to value-based care.


Breaking down the new price transparency executive order

Read More

Cost accounting adoption, slow for decades, now at hyper speed

Read More

CMS proposes rule requiring providers to publish payer-negotiated healthcare rates

Read More

New Trump Administration executive order targets healthcare price transparency

Read More

Docs taking on full risk in value-based care models still years away

Read More

INTERVIEW: Creating a Healthcare Partnership Focused on Value

Read More

UnitedHealthcare to expand Medicare Advantage bundled payment arrangements

Read More

Defining Value - The Foundation Of Outcomes-Based Risk-Sharing Agreements

Read More

New Marketplace Insights: Value in Health Care

Read More

Medtronic, Blue Cross sign glucose monitor deal linked to patient outcomes

Read More

The cost of medical device
innovation: can we keep pace?

Read More

Driving value across the enterprise: Health execs have a laser focus on analytics

Read More

event recap

Leading the Conversation: Where are the ‘New and Improved’ Outcomes in Health?

juNE 24, 2019

q&a with healthcare leaders

For The Record with Nicole fetter


Nicole Fetter is a Director in the Healthcare Services practice. She trained as an Orthopedic Surgeon and has experience in population health, physician alignment, value-based care models, orthopedic surgery, OR operations improvement, and health system strategic growth. Nicole has worked with a wide variety of healthcare providers including academic medical centers, community hospitals, large for-profit health systems and not-for-profit health systems. She has worked with health systems to assess, build and implement capabilities to support value-based care.

For The Record with JOE GALATOWITSCH


Joe pioneered the Science of Market Development, which has been adopted and used by leading medtech companies around the globe. He has led more than 100 medical technology market assessments in numerous technologies, diseases, and geographies. Additionally, he has managed a $120 million global commercial medtech business and also led many successful medtech market development initiatives, including the ICD market expansion, which led to more than $2 billion in growth in less than 24 months.

For The Record with MUNZOOR SHAIKH


Munzoor Shaikh is a Director in West Monroe’s Healthcare practice and leads the Healthcare Transaction Services as well as the Provider/Population Health practice. He has completed nearly 200 due diligence transactions and several dozen post-close mergers/divestitures. For providers, he focuses on transformational opportunities from Digital Transformation to business and technology changes needed to actualize Value Based Care. Munzoor has more than 18 years of consulting experience in management and technology.


Put Your Brand In Front of the leaders of medical alley

SPONSOR leading the conversation

Leading the Conversation is a half day leadership forum, featuring discussion from executives and leaders around the evolution of healthcare and the implications, opportunities, and challenges for innovators. In 2019, MAA will host two Leading the Conversation events. 


Attendees Per Event

C-suite executives, directors and managers from digital health, payor, provider, pharmaceuticals & more! 

$99 - Members 

$299 - Non-Members 

See more information here or contact Frank Jaskulke, VP of Intelligence at or 952-746-3814.

event recap

new models in addressing mental health

july 25, 2018

Looking at mental health objectively with medibio

q&a with healthcare leaders

For The Record with MARK WALINSKE

Revo Health

Mark Walinske has over 34 years of early-stage entrepreneurial experience with 15 years being in healthcare. Mark has always had a deep passion for advancing organizations and technologies to reverse the rising costs in healthcare. Prior to joining Revo Health, an organization focused on enabling value-based care, Mark was an executive at Optum in the Innovation R&D organization.


Philips Sleep and Respiratory Care

Dr. Ehlen is a healthcare leader, executive and physician with deep experience in medical technology and healthcare system management. Dr. Ehlen has spent more than a decade leading medical device organizations including Halleland Health Consulting and RespirTech, which was acquired by Philips in 2017.

Jill Wiedemann-West 

CEO, People Incorporated Mental Health Services

Master of Arts in Psychology and Human Behavior from National University in San Diego, Bachelor of Arts in Sociology and Social Work from the University of Wisconsin-Madison. Before joining People Incorporated, she was COO at Hazelden Betty Ford Foundation for 11 years.

Brendan Shane

DIRECTOR, Behavioral Health Operations with Bcbs of MN

Brendan holds a Master of Social Work degree from the University of St. Thomas, St. Paul, and a Master of Business Administration from Capella University. Prior to Blue Cross Blue Shield of Minnesota, Brendan was the Director of Clinical Care Services for Magellan of Virginia.

Leading the conversation - in the news

This company is using biometric data to address mental health

Medibio's technology relies on biometrics (like a person's heart rate and sleep patterns) to gain insight into factors influencing an individual's mental health.

Mental health is not something that can be brushed under the rug. We’ve come to a point where we’re seeing how big of a role it plays in everyone’s lives and how crucial it is for people to get help when they need it. In the medical world, organizations are striving to integrate behavioral and physical health. More specifically, one company is looking at the intersection of mental health and biometric data.

Read more

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER